[1] Itoh S,Yugawa K,Shimokawa M,et al.Prognostic significance of inflammatory biomarkers in hepatocellular carcinoma following hepatic resection[J].BJS Open,2019,3(4):500-508. [2] Oikonomou T, Goulis I, Kiapidou S, et al. The significance of C-reactive protein to albumin ratio in patients with decompensated cirrhosis[J]. Ann Gastroenterol.2020,33(6):667-674. [3] Salehi A, Dehghani S M, Vardenjani H M,et al.Comparison of lymphocyte-to-monocyte ratio with Child-Pugh and PELD/MELD scores to predict the outcome of children with cirrhosis[J]. Clin Exp Hepatol,2021,7(4):351-357. [4] Moosmann J, Krusemark A, Dittrich S, et al.Age-and sex-specific pediatric reference intervals for neutrophil-to-lymphocyte ratio,lymphocyte-to-monocyte ratio,and platelet-to-lymphocyte ratio[J]. Int J Lab Hematol,2022,44(2):296-301. [5] Piotrowski D,Səczewska-Piotrowska A,Jaroszewicz J,et al. Lymphocyte-to-monocyte ratio as the best simple predictor of bacterial infection in patients with liver cirrhosis[J].Int J Environ Res Public Health,2020,17(5):1727. [6] Wu Z, Cui L, Qian J, et al. Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China[J].BMC Cancer,2023,23(1):325. [7] Mallik M, Singhai A, Khadanga S, et al. The significant morbidity and mortality indicators in patients of cirrhosis[J].Cureus,2022,14(1):e21226. [8] Dejanović B, Barak O, Čolović P, et al. Hospital mortality in acute decompensation of alcoholic liver cirrhosis: can novel survival markers outperform traditional Ones[J].J Clin Med,2024,13(20):6208. [9] Hsu Y C, Yang Y Y, Tsai I T.Lymphocyte-to-monocyte ratio predicts mortality in cirrhotic patients with septic shock[J].Am J Emerg Med,2021(2):40:70-76. [10] Jalan R, Saliba F, Pavesi M, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure[J]. J Hepatol,2014,61(5):1038-1047. [11] Zhou X D, Zhang J Y, Liu W Y,et al.Quick chronic liver failure-sequential organ failure assessment: an easy-to-use scoring model for predicting mortality risk in critically ill cirrhosis patients[J]. Eur J Gastroenterol Hepatol,2017,29(6):698-705. [12] Lee N Y, Suk K T.The role of the gut microbiome in liver cirrhosis treatment[J].Int J Mol Sci,2020,22(1):199. [13] Zhang J, Feng G, Zhao Y,et al.Association between lymphocyte-tomonocyte ratio (LMR) and the mortality of HBV-related liver cirrhosis:a retrospective cohort study[J].BMJ Open, 2015,5(8):e008033. [14] Jamil Z, Durrani A A.Assessing the outcome of patients with liver cirrhosis during hospital stay:a comparison of lymphocyte/monocyte ratio with MELD and Child-Pugh scores[J].Turk J Gastroenterol,2018,29(3):308-315. [15] Song W, Tian C, Wang K, et al. The pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with hepatocellular carcinoma: a meta-analysis[J].Sci Rep,2017,7:46601. [16] Zhao K, Wang C, Shi F,et al.Lymphocyte-monocyte ratio as a predictive marker for pathological complete response to neoadjuvant therapy in esophageal squamous cell carcinoma[J]. Transl Cancer Res,2020,9(6):3842-3853. [17] Lin Z X, Ruan D Y, Li Y, et al.Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection[J].World J Gastroenterol,2015,21(38):10898-10906. [18] Karvellas C J, Bajaj J S, Kamath P S, et al.AASLD Practice Guidance on acute-on-chronic liver failure and the management of critically ill patients with cirrhosis[J]. Hepatology,2024,79(6):1463-1502. |